Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Marina Maurer
Pharmacokinetics of Gemcitabine in Non-Small-Cell Lung Cancer Patients: Impact of the 79A>C Cytidine Deaminase Polymorphism
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Related publications
Cytidine Deaminase Enzymatic Activity Is a Prognostic Biomarker in Gemcitabine/Platinum-Treated Advanced Non-Small-Cell Lung Cancer: A Prospective Validation Study
British Journal of Cancer
Cancer Research
Oncology
Paclitaxel Alters the Expression and Specific Activity of Deoxycytidine Kinase and Cytidine Deaminase in Non-Small Cell Lung Cancer Cell Lines
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Adverse Prognostic Impact of TGFB1 T869C Polymorphism in Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Combination Studies With Gemcitabine in the Treatment of Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients With Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Metastatic Non-Small-Cell Lung Cancer and the Use of Gemcitabine During Pregnancy
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
RRM1 Expression and the Clinicopathological Characteristics of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine
OncoTargets and Therapy
Oncology
Pharmacology
